AstraZeneca said on Friday its and Daiichi Sankyo's cancer drug Enhertu was recommended by the European Medicines Agency's human medicines committee as a monotherapy to treat patients with a type of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback